Report Detail

Request for Sample of this report

Pharma & Healthcare Global Primary Myelofibrosis (PMF) Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4742494
    • |
  • 28 September, 2026
    • |
  • Global
    • |
  • 87 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Primary Myelofibrosis (PMF) market size was valued at US$ 172 million in 2025 and is forecast to a readjusted size of US$ 321 million by 2032 with a CAGR of 9.4% during review period.
Primary myelofibrosis (MF) is a chronic blood cancer in which excessive scar tissue forms in the bone marrow and impairs its ability to produce normal blood cells. Researchers believe MF may be caused by abnormal blood stem cells in the bone marrow. The abnormal stem cells produce mature cells that grow quickly and take over the bone marrow, causing both fibrosis (scar tissue formation) and chronic inflammation. The statistic scope is primary myelofibrosis drug in this report.
This report is a detailed and comprehensive analysis for global Primary Myelofibrosis (PMF) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Primary Myelofibrosis (PMF) market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Primary Myelofibrosis (PMF) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Primary Myelofibrosis (PMF) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Primary Myelofibrosis (PMF) market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Primary Myelofibrosis (PMF)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Primary Myelofibrosis (PMF) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, AbbVie, Novartis, Celgene, Grunenthal, Incyte, CTI BioPharma, Bristol Myers Squibb, Suzhou Zelgen Biopharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Primary Myelofibrosis (PMF) market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
JAK 1
JAK 2
Others
Market segment by Application
Adults
Children
Major players covered
GSK
AbbVie
Novartis
Celgene
Grunenthal
Incyte
CTI BioPharma
Bristol Myers Squibb
Suzhou Zelgen Biopharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Primary Myelofibrosis (PMF) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Primary Myelofibrosis (PMF), with price, sales quantity, revenue, and global market share of Primary Myelofibrosis (PMF) from 2021 to 2026.
Chapter 3, the Primary Myelofibrosis (PMF) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Primary Myelofibrosis (PMF) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Primary Myelofibrosis (PMF) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Primary Myelofibrosis (PMF).
Chapter 14 and 15, to describe Primary Myelofibrosis (PMF) sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Primary Myelofibrosis (PMF) Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 JAK 1
    • 1.3.3 JAK 2
    • 1.3.4 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Primary Myelofibrosis (PMF) Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Adults
    • 1.4.3 Children
  • 1.5 Global Primary Myelofibrosis (PMF) Market Size & Forecast
    • 1.5.1 Global Primary Myelofibrosis (PMF) Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Primary Myelofibrosis (PMF) Sales Quantity (2021-2032)
    • 1.5.3 Global Primary Myelofibrosis (PMF) Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 GSK
    • 2.1.1 GSK Details
    • 2.1.2 GSK Major Business
    • 2.1.3 GSK Primary Myelofibrosis (PMF) Product and Services
    • 2.1.4 GSK Primary Myelofibrosis (PMF) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 GSK Recent Developments/Updates
  • 2.2 AbbVie
    • 2.2.1 AbbVie Details
    • 2.2.2 AbbVie Major Business
    • 2.2.3 AbbVie Primary Myelofibrosis (PMF) Product and Services
    • 2.2.4 AbbVie Primary Myelofibrosis (PMF) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 AbbVie Recent Developments/Updates
  • 2.3 Novartis
    • 2.3.1 Novartis Details
    • 2.3.2 Novartis Major Business
    • 2.3.3 Novartis Primary Myelofibrosis (PMF) Product and Services
    • 2.3.4 Novartis Primary Myelofibrosis (PMF) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Novartis Recent Developments/Updates
  • 2.4 Celgene
    • 2.4.1 Celgene Details
    • 2.4.2 Celgene Major Business
    • 2.4.3 Celgene Primary Myelofibrosis (PMF) Product and Services
    • 2.4.4 Celgene Primary Myelofibrosis (PMF) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Celgene Recent Developments/Updates
  • 2.5 Grunenthal
    • 2.5.1 Grunenthal Details
    • 2.5.2 Grunenthal Major Business
    • 2.5.3 Grunenthal Primary Myelofibrosis (PMF) Product and Services
    • 2.5.4 Grunenthal Primary Myelofibrosis (PMF) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Grunenthal Recent Developments/Updates
  • 2.6 Incyte
    • 2.6.1 Incyte Details
    • 2.6.2 Incyte Major Business
    • 2.6.3 Incyte Primary Myelofibrosis (PMF) Product and Services
    • 2.6.4 Incyte Primary Myelofibrosis (PMF) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Incyte Recent Developments/Updates
  • 2.7 CTI BioPharma
    • 2.7.1 CTI BioPharma Details
    • 2.7.2 CTI BioPharma Major Business
    • 2.7.3 CTI BioPharma Primary Myelofibrosis (PMF) Product and Services
    • 2.7.4 CTI BioPharma Primary Myelofibrosis (PMF) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 CTI BioPharma Recent Developments/Updates
  • 2.8 Bristol Myers Squibb
    • 2.8.1 Bristol Myers Squibb Details
    • 2.8.2 Bristol Myers Squibb Major Business
    • 2.8.3 Bristol Myers Squibb Primary Myelofibrosis (PMF) Product and Services
    • 2.8.4 Bristol Myers Squibb Primary Myelofibrosis (PMF) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Bristol Myers Squibb Recent Developments/Updates
  • 2.9 Suzhou Zelgen Biopharmaceuticals
    • 2.9.1 Suzhou Zelgen Biopharmaceuticals Details
    • 2.9.2 Suzhou Zelgen Biopharmaceuticals Major Business
    • 2.9.3 Suzhou Zelgen Biopharmaceuticals Primary Myelofibrosis (PMF) Product and Services
    • 2.9.4 Suzhou Zelgen Biopharmaceuticals Primary Myelofibrosis (PMF) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Suzhou Zelgen Biopharmaceuticals Recent Developments/Updates

3 Competitive Environment: Primary Myelofibrosis (PMF) by Manufacturer

  • 3.1 Global Primary Myelofibrosis (PMF) Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Primary Myelofibrosis (PMF) Revenue by Manufacturer (2021-2026)
  • 3.3 Global Primary Myelofibrosis (PMF) Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Primary Myelofibrosis (PMF) by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Primary Myelofibrosis (PMF) Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Primary Myelofibrosis (PMF) Manufacturer Market Share in 2025
  • 3.5 Primary Myelofibrosis (PMF) Market: Overall Company Footprint Analysis
    • 3.5.1 Primary Myelofibrosis (PMF) Market: Region Footprint
    • 3.5.2 Primary Myelofibrosis (PMF) Market: Company Product Type Footprint
    • 3.5.3 Primary Myelofibrosis (PMF) Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Primary Myelofibrosis (PMF) Market Size by Region
    • 4.1.1 Global Primary Myelofibrosis (PMF) Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Primary Myelofibrosis (PMF) Consumption Value by Region (2021-2032)
    • 4.1.3 Global Primary Myelofibrosis (PMF) Average Price by Region (2021-2032)
  • 4.2 North America Primary Myelofibrosis (PMF) Consumption Value (2021-2032)
  • 4.3 Europe Primary Myelofibrosis (PMF) Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Primary Myelofibrosis (PMF) Consumption Value (2021-2032)
  • 4.5 South America Primary Myelofibrosis (PMF) Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Primary Myelofibrosis (PMF) Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Primary Myelofibrosis (PMF) Sales Quantity by Type (2021-2032)
  • 5.2 Global Primary Myelofibrosis (PMF) Consumption Value by Type (2021-2032)
  • 5.3 Global Primary Myelofibrosis (PMF) Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Primary Myelofibrosis (PMF) Sales Quantity by Application (2021-2032)
  • 6.2 Global Primary Myelofibrosis (PMF) Consumption Value by Application (2021-2032)
  • 6.3 Global Primary Myelofibrosis (PMF) Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Primary Myelofibrosis (PMF) Sales Quantity by Type (2021-2032)
  • 7.2 North America Primary Myelofibrosis (PMF) Sales Quantity by Application (2021-2032)
  • 7.3 North America Primary Myelofibrosis (PMF) Market Size by Country
    • 7.3.1 North America Primary Myelofibrosis (PMF) Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Primary Myelofibrosis (PMF) Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Primary Myelofibrosis (PMF) Sales Quantity by Type (2021-2032)
  • 8.2 Europe Primary Myelofibrosis (PMF) Sales Quantity by Application (2021-2032)
  • 8.3 Europe Primary Myelofibrosis (PMF) Market Size by Country
    • 8.3.1 Europe Primary Myelofibrosis (PMF) Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Primary Myelofibrosis (PMF) Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Primary Myelofibrosis (PMF) Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Primary Myelofibrosis (PMF) Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Primary Myelofibrosis (PMF) Market Size by Region
    • 9.3.1 Asia-Pacific Primary Myelofibrosis (PMF) Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Primary Myelofibrosis (PMF) Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Primary Myelofibrosis (PMF) Sales Quantity by Type (2021-2032)
  • 10.2 South America Primary Myelofibrosis (PMF) Sales Quantity by Application (2021-2032)
  • 10.3 South America Primary Myelofibrosis (PMF) Market Size by Country
    • 10.3.1 South America Primary Myelofibrosis (PMF) Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Primary Myelofibrosis (PMF) Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Primary Myelofibrosis (PMF) Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Primary Myelofibrosis (PMF) Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Primary Myelofibrosis (PMF) Market Size by Country
    • 11.3.1 Middle East & Africa Primary Myelofibrosis (PMF) Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Primary Myelofibrosis (PMF) Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Primary Myelofibrosis (PMF) Market Drivers
  • 12.2 Primary Myelofibrosis (PMF) Market Restraints
  • 12.3 Primary Myelofibrosis (PMF) Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Primary Myelofibrosis (PMF) and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Primary Myelofibrosis (PMF)
  • 13.3 Primary Myelofibrosis (PMF) Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Primary Myelofibrosis (PMF) Typical Distributors
  • 14.3 Primary Myelofibrosis (PMF) Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Primary Myelofibrosis (PMF). Industry analysis & Market Report on Primary Myelofibrosis (PMF) is a syndicated market report, published as Global Primary Myelofibrosis (PMF) Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Primary Myelofibrosis (PMF) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo